Choice of antiplatelet therapy. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy5

Blood Platelets Coronary Vessels Carotid Arteries Platelet-Rich Plasma Melena

Organisms4

Goniothalamus Magnolia Crinum Murraya

Diseases52

Hemorrhage Thrombosis Coronary Thrombosis Acute Coronary Syndrome Stroke Myocardial Infarction Coronary Artery Disease Postoperative Hemorrhage Thromboembolism Coronary Restenosis Recurrence Graft Occlusion, Vascular Ischemic Attack, Transient Coronary Disease Intracranial Hemorrhages Intracranial Thrombosis Peripheral Vascular Diseases Brain Ischemia Cardiovascular Diseases Embolism Blood Loss, Surgical Cerebral Hemorrhage Hematoma Cerebrovascular Disorders Coronary Stenosis Gastrointestinal Hemorrhage Myocardial Ischemia Postoperative Complications Thrombocythemia, Essential Atrial Fibrillation Angina, Unstable Intracranial Embolism Diabetic Angiopathies Arterial Occlusive Diseases Intracranial Aneurysm Ischemia Carotid Stenosis Thrombocytopenia Carotid Artery Diseases Purpura, Thrombocytopenic Atherosclerosis Acute Disease Heart Diseases Acute Lung Injury Purpura, Thrombocytopenic, Idiopathic Embolism, Cholesterol Carotid Artery Thrombosis Diabetes Mellitus, Type 2 Trigger Finger Disorder Melena Oral Hemorrhage Thrombocytosis

Chemicals and Drugs54

Platelet Aggregation Inhibitors Ticlopidine Aspirin Purinergic P2Y Receptor Antagonists Phenprocoumon Anticoagulants Receptors, Purinergic P2Y12 Thiophenes Dipyridamole Fibrinolytic Agents Thienopyridines Warfarin Tetrazoles Platelet Glycoprotein GPIIb-IIIa Complex Sirolimus Pyridines Piperazines Purinergic P2 Receptor Antagonists Acenocoumarol Heparin Thromboxanes Cardiovascular Agents Pyridones Aryl Hydrocarbon Hydroxylases Adenosine Diphosphate Heparin, Low-Molecular-Weight Immunoglobulin Fab Fragments Drug Combinations Coated Materials, Biocompatible Proton Pump Inhibitors Thromboxane B2 Receptors, Purinergic P2 Adenosine Phosphodiesterase 3 Inhibitors Metals Sulfinpyrazone Paclitaxel Phenazopyridine Platelet Membrane Glycoproteins Dilazep Antithrombins P-Selectin Thromboxane A2 Tablets, Enteric-Coated Hirudins Receptor, PAR-1 Collagen Hemostatics Thromboxane-A Synthase Cyclooxygenase Inhibitors Hydroxymethylglutaryl-CoA Reductase Inhibitors Isoindoles Thrombin Quinidine

Analytical, Diagnostic and Therapeutic Techniques and Equipment74

Drug Therapy, Combination Platelet Function Tests Stents Drug-Eluting Stents Angioplasty, Balloon, Coronary Treatment Outcome Risk Factors Percutaneous Coronary Intervention Prospective Studies Follow-Up Studies Risk Assessment Perioperative Care Thrombelastography Randomized Controlled Trials as Topic Platelet Count Prosthesis Design Coronary Angiography Administration, Oral Retrospective Studies Drug Administration Schedule Withholding Treatment Registries Double-Blind Method Propensity Score Clinical Trials as Topic Drug Monitoring Incidence International Normalized Ratio Thrombolytic Therapy Bleeding Time Kaplan-Meier Estimate Chi-Square Distribution Premedication Postoperative Care Retreatment Surgical Procedures, Elective Angioplasty Angioscopy Endovascular Procedures Vascular Surgical Procedures Proportional Hazards Models Surgical Procedures, Operative Endarterectomy, Carotid Cohort Studies Blood Vessel Prosthesis Implantation Logistic Models Embolization, Therapeutic Multivariate Analysis Blood Transfusion Blood Vessel Prosthesis Ultrasonography, Doppler, Transcranial Angioplasty, Balloon Odds Ratio Coronary Artery Bypass Myocardial Revascularization Combined Modality Therapy Risk Prognosis Clinical Protocols Patient Selection Pilot Projects Tomography, X-Ray Computed Cerebral Angiography Ultrasonography, Interventional Electrocardiography Predictive Value of Tests Research Design Severity of Illness Index Survival Rate Regression Analysis Disease-Free Survival Survival Analysis Platelet Transfusion Drug Incompatibility

Psychiatry and Psychology3

Career Choice Medication Adherence Decision Making

Phenomena and Processes16

Platelet Aggregation Platelet Activation Time Factors Drug Resistance Platelet Count Dose-Response Relationship, Drug Bleeding Time Drug Interactions Chi-Square Distribution Vascular Patency Blood Coagulation Odds Ratio Risk Platelet Adhesiveness Polymorphism, Genetic Herb-Drug Interactions

Disciplines and Occupations2

Evidence-Based Medicine Research Design

Technology, Industry, Agriculture1

Coated Materials, Biocompatible

Information Science3

Registries Incidence Survival Rate

Health Care42

Treatment Outcome Risk Factors Prospective Studies Follow-Up Studies Secondary Prevention Risk Assessment Perioperative Care Randomized Controlled Trials as Topic Retrospective Studies Point-of-Care Systems Withholding Treatment Registries Practice Guidelines as Topic Double-Blind Method Propensity Score Clinical Trials as Topic Incidence Kaplan-Meier Estimate Chi-Square Distribution Postoperative Care Societies, Medical Proportional Hazards Models Cohort Studies Logistic Models Multivariate Analysis Physician's Practice Patterns Odds Ratio Risk Clinical Protocols Patient Selection Pilot Projects Medication Adherence Predictive Value of Tests Severity of Illness Index Cost-Benefit Analysis Age Factors Survival Rate Sex Factors Comorbidity Regression Analysis Disease-Free Survival Survival Analysis

Geographicals3

France Japan United States

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care Geographicals

Platelet Aggregation Inhibitors Ticlopidine Aspirin Hemorrhage Drug Therapy, Combination Thrombosis Platelet Function Tests Platelet Aggregation Coronary Thrombosis Purinergic P2Y Receptor Antagonists Phenprocoumon Stents Anticoagulants Receptors, Purinergic P2Y12 Acute Coronary Syndrome Drug-Eluting Stents Angioplasty, Balloon, Coronary Thiophenes Treatment Outcome Dipyridamole Blood Platelets Fibrinolytic Agents Platelet Activation Thienopyridines Stroke Myocardial Infarction Warfarin Tetrazoles Time Factors Risk Factors Platelet Glycoprotein GPIIb-IIIa Complex Coronary Artery Disease Percutaneous Coronary Intervention Prospective Studies Follow-Up Studies Postoperative Hemorrhage Secondary Prevention Thromboembolism Risk Assessment Perioperative Care Drug Resistance Coronary Restenosis Thrombelastography Recurrence Randomized Controlled Trials as Topic Sirolimus Graft Occlusion, Vascular Platelet Count Pyridines Prosthesis Design Piperazines Ischemic Attack, Transient Purinergic P2 Receptor Antagonists Coronary Angiography Acenocoumarol Administration, Oral Coronary Disease Retrospective Studies Intracranial Hemorrhages Intracranial Thrombosis Drug Administration Schedule Peripheral Vascular Diseases Heparin Thromboxanes Brain Ischemia Cardiovascular Diseases Embolism Cardiovascular Agents Point-of-Care Systems Blood Loss, Surgical Withholding Treatment Registries Cerebral Hemorrhage Practice Guidelines as Topic Double-Blind Method Propensity Score Hematoma Clinical Trials as Topic Cerebrovascular Disorders Pyridones Coronary Stenosis Drug Monitoring Gastrointestinal Hemorrhage Myocardial Ischemia Incidence International Normalized Ratio Aryl Hydrocarbon Hydroxylases Adenosine Diphosphate Heparin, Low-Molecular-Weight Thrombolytic Therapy Postoperative Complications Thrombocythemia, Essential Dose-Response Relationship, Drug Bleeding Time Immunoglobulin Fab Fragments Kaplan-Meier Estimate Drug Interactions Atrial Fibrillation Drug Combinations Chi-Square Distribution

No FAQ available that match "choice of antiplatelet therapy"